Date lodged: 6 July 2017
To ask the Scottish Government when the Cabinet Secretary for Health and Sport will respond to the recommendations of the review by Dr Brian Montgomery and what the implications are for access to precision medicines such as Orkambi for people living with cystic fibrosis.
Answered by: Shona Robison 28 July 2017
Dr Montgomery’s independent review on access to new medicines recognised that the Scottish Government has made significant reforms and investment to improve access to newly licensed medicines in recent years.
I announced in December 2016 that we will be taking forward the recommendations from the review. We are working at pace, in collaboration with stakeholders, including the Scottish Medicines Consortium, NHS Scotland, and the pharmaceutical industry to implement the recommendations as quickly as possible.